跳至主要内容
临床试验/NCT04982198
NCT04982198已完成不适用

Robotic-assisted Versus Conventional Total Knee Arthroplasty: A Multicenter and Randomized Controlled Clinical Trial

Zimmer Biomet1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2021年7月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Zimmer Biomet
入组人数
99
试验地点
1
主要终点
Mechanical axis alignment

研究概览

简要总结

This is a multicenter, prospective and randomized controlled pre-market clinical Trial. Study subjects will be randomized into one of two operative groups: 1) TKA assisted with ROSA® Knee System; 2) TKA with conventional surgical instrumentation.

详细描述

The objective of this clinical trial is to measure the effectiveness and safety of the ROSA® Knee System in assisting surgeons with bone resections and implant positioning optimization through early clinical and radiographic outcomes compared with conventional surgical instrumentation in total knee arthroplasty (TKA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is age between 18 and 85 years old, inclusive;
  • Patient qualifies for a primary TKA based on the investigator's clinical judgement;
  • Patient is a candidate for commercially available Persona® Knee Joint Prosthese which is compatible with the ROSA® Knee System;
  • Patient is willing and able to provide written Informed Consent.

排除标准

  • Patient planning to receive bilateral TKA surgery within 3 months;
  • Patient who has undergone revision surgery for partial or total knee arthroplasty of the ipsilateral knee;
  • Bone tumor patient who has undergone bilateral TKA;
  • Stable, painless ipsilateral knee arthrodesis within a satisfactory function and position;
  • Patient who has received partial or total knee arthroplasty for the contralateral knee within 6 months prior to scheduled primary TKA;
  • Patient has active, local infection or previous intra-articular infection in the affected joint;
  • Insufficient bone stock on femoral or tibial surfaces;
  • Skeletal immaturity;
  • Osteomalacia or any metabolic disorder which may impair bone formation;
  • Patient has neurologic disorders (e.g. Stroke);
  • Patient hs diseases that could lead to prosthesis instability, failure of prosthesis fixation or postoperative complications (e.g. Arthrodesis, Scoliosis, Lumbar Stenosis)
  • Patient has a hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum);
  • Patient has hip pathology severely limiting range of motion (e.g. arthrodesis, severe contractures, chronic severe dislocation);
  • Patients with severe knee instability caused by incomplete collateral ligaments, cruciate ligaments, and posterolateral structural injury;
  • Rheumatoid arthritis accompanied by an ulcer of the skin or history of recurrent breakdown of the skin;
  • Patient has severe angular knee deformity of >20° varus or >20° valgus;
  • Patient has a known or suspected sensitivity or allergy to one or more of the implant materials;
  • Patient has other contraindications specified by the implant manufacturer;
  • Patient is pregnant or considered a member of a protected population (e.g. prisoner, mentally incompetent);
  • In the past 1 month participated in or is participating in clinical trials related to other drugs and medical devices;
  • Any other conditions that the investigator considers inappropriate for participation in this trial.

结局指标

主要结局

Mechanical axis alignment

时间窗: 6 weeks (±2 week) postoperatively

Deviation from neutral mechanical axis alignment based on full-leg weight-bearing X-ray at 6 weeks (±2 week) postoperatively.

次要结局

  • Coronal Lower Limb Alignment(6 weeks (±2 week) postoperatively)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验